UPCI Hillman Cancer Center — Pittsburgh, Pennsylvania

UPCI Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

UPCI Hillman Cancer Center has participated in 3 clinical trials.

Therapeutic areas: Multiple Myeloma, Advanced Malignancies, Advanced Cancer.

Sponsors: Celgene, Astellas Pharma Global Development, Inc., Ahmad Tarhini.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPCI Hillman Cancer Center?

UPCI Hillman Cancer Center has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPCI Hillman Cancer Center conducted?

UPCI Hillman Cancer Center has 3 clinical trials on record. Their work covers Multiple Myeloma, Advanced Malignancies, Advanced Cancer.

Is UPCI Hillman Cancer Center accredited by Crixeo Health?

UPCI Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPCI Hillman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.